PAVmed Inc. (PAVM)

PAVmed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	19.64	39.74	77.26	17.26	6.22
Cash & Cash Equivalents	19.64	39.74	77.26	17.26	6.22
Cash Growth	-50.59%	-48.56%	347.72%	177.47%	-24.36%
Receivables	0.06	0.02	0.2	0	0
Inventory	0.28	0.11	0	0	0
Other Current Assets	4.52	4.05	5.18	1.69	0.33
Total Current Assets	24.5	43.93	82.64	18.94	6.55
Property, Plant & Equipment	6.05	5.49	1.59	0.08	0
Goodwill and Intangibles	1.42	3.45	2.03	0	0
Other Long-Term Assets	1.15	1.12	0.73	0.76	0.69
Total Long-Term Assets	8.62	10.05	4.34	0.84	0.69
Total Assets	33.12	53.98	86.98	19.78	7.24
Accounts Payable	1.79	2.7	3.3	2.97	2.35
Current Debt	45.77	34.79	0	14.96	8.14
Other Current Liabilities	6.63	3.71	4.26	2.33	1.39
Total Current Liabilities	54.18	41.2	7.56	20.25	11.88
Long-Term Debt	2.96	1.85	0	0	0
Total Long-Term Liabilities	2.96	1.85	0	0	0
Total Liabilities	57.14	43.05	7.56	20.25	11.88
Total Debt	48.73	36.64	0	14.96	8.14
Debt Growth	32.99%	-	-	83.81%	2.99%
Retained Earnings	-294.43	-228.17	-138.91	-88.28	-53.72
Shareholders' Equity	-53.83	-9.68	61.67	1.9	-3.82
Net Cash / Debt	-29.09	3.11	77.26	2.3	-1.92
Net Cash / Debt Growth	-	-95.98%	3264.90%	-	-
Net Cash Per Share	-4.02	0.52	14.95	0.73	-0.95
Working Capital	-29.68	2.73	75.08	-1.31	-5.33
Book Value Per Share	-7.44	-1.63	11.93	0.60	-1.90

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).